-
1
-
-
0022505110
-
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFe (Multiple Risk Factor Intervention Trial)
-
Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFe (Multiple Risk Factor Intervention Trial). Am Heart J 1986;112:825-36
-
(1986)
Am Heart J
, vol.112
, pp. 825-836
-
-
Kannel, W.B.1
Neaton, J.D.2
Wentworth, D.3
-
2
-
-
0023025526
-
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
-
Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8
-
(1986)
JAMA
, vol.256
, pp. 2823-2828
-
-
Stamler, J.1
Wentworth, D.2
Neaton, J.D.3
-
3
-
-
0023880042
-
High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: The Framingham Study
-
Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study. Arteriosclerosis 1988;8:207-11
-
(1988)
Arteriosclerosis
, vol.8
, pp. 207-211
-
-
Abbott, R.D.1
Wilson, P.W.2
Kannel, W.B.3
Castelli, W.P.4
-
4
-
-
0023029454
-
Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
-
Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986;256:2835-8
-
(1986)
JAMA
, vol.256
, pp. 2835-2838
-
-
Castelli, W.P.1
Garrison, R.J.2
Wilson, P.W.3
-
5
-
-
0028174806
-
Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
-
Sharrett AR, Patsch W, Sorlie PD, et al. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994;14:1098-104
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1098-1104
-
-
Sharrett, A.R.1
Patsch, W.2
Sorlie, P.D.3
-
6
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
7
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators
-
Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
8
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
-
Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
9
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study)
-
Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study). JAMA 1998;279:1615-22
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
10
-
-
0037031061
-
MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group. MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
11
-
-
0035818556
-
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part I
-
Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 2001;104:2376-83
-
(2001)
Circulation
, vol.104
, pp. 2376-2383
-
-
Shah, P.K.1
Kaul, S.2
Nilsson, J.3
Cercek, B.4
-
12
-
-
0029759109
-
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
-
Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(Suppl):S11-20
-
(1996)
Atherosclerosis
, vol.124
, Issue.SUPPL.
-
-
Assmann, G.1
Schulte, H.2
von Eckardstein, A.3
Huang, Y.4
-
13
-
-
0017384270
-
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
-
Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14
-
(1977)
Am J Med
, vol.62
, pp. 707-714
-
-
Gordon, T.1
Castelli, W.P.2
Hjortland, M.C.3
-
14
-
-
0024501678
-
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
-
Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15
-
(1989)
Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
Probstfield, J.L.2
Garrison, R.J.3
-
15
-
-
34447520136
-
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
-
Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16
-
(2007)
JAMA
, vol.298
, pp. 309-316
-
-
Bansal, S.1
Buring, J.E.2
Rifai, N.3
-
16
-
-
34447511196
-
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
-
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308
-
(2007)
JAMA
, vol.298
, pp. 299-308
-
-
Nordestgaard, B.G.1
Benn, M.2
Schnohr, P.3
Tybjaerg-Hansen, A.4
-
18
-
-
29144452513
-
High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients
-
Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients. Curr Med Res Opin 2005;21:1927-34
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 1927-1934
-
-
Bruckert, E.1
Baccara-Dinet, M.2
McCoy, F.3
Chapman, J.4
-
19
-
-
33748559051
-
Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey
-
Farmer M, Garnier P, Yau C, et al. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey. Int J Clin Pract 2006;60:1166-71
-
(2006)
Int J Clin Pract
, vol.60
, pp. 1166-1171
-
-
Farmer, M.1
Garnier, P.2
Yau, C.3
-
20
-
-
3042695179
-
The lipid audit: Analysis of lipid management in two centres in Britain 2003
-
Patel JV, Kirby M, Hughes EA. The lipid audit: analysis of lipid management in two centres in Britain 2003. Br J Cardiol 2004;11:2147
-
(2004)
Br J Cardiol
, vol.11
, pp. 2147
-
-
Patel, J.V.1
Kirby, M.2
Hughes, E.A.3
-
21
-
-
4644279733
-
Increasing prevalence of the metabolic syndrome among U.S. adults
-
Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-9
-
(2004)
Diabetes Care
, vol.27
, pp. 2444-2449
-
-
Ford, E.S.1
Giles, W.H.2
Mokdad, A.H.3
-
22
-
-
34247862362
-
Blood pressure and estimated risk of stroke in the elderly population of Spain: The PREV-ICTUS study
-
Redon J, Cea-Calvo L, Lozano JV, et al. Blood pressure and estimated risk of stroke in the elderly population of Spain: The PREV-ICTUS study. Stroke 2007;38:1167-73
-
(2007)
Stroke
, vol.38
, pp. 1167-1173
-
-
Redon, J.1
Cea-Calvo, L.2
Lozano, J.V.3
-
23
-
-
0042512336
-
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
-
De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10
-
(2003)
Eur Heart J
, vol.24
, pp. 1601-1610
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
-
24
-
-
19944363489
-
Adaptación Española de la Guia de Prevención Cardiovascular (I). [Spanish adaptation of the European Guide to Cardiovascular Prevention (I)]
-
Brotons C, Royo-Bordonada MA, Alvarez-Sala L, et al. Adaptación Española de la Guia de Prevención Cardiovascular (I). [Spanish adaptation of the European Guide to Cardiovascular Prevention (I)]. Aten Primaria 2004;34:427-32
-
(2004)
Aten Primaria
, vol.34
, pp. 427-432
-
-
Brotons, C.1
Royo-Bordonada, M.A.2
Alvarez-Sala, L.3
-
25
-
-
41149155887
-
-
Instituto Nacional de Estadistica de España (Nacional Institute of Statistics of Spain). Cifras de Población. Available at: http://www.ine.es/inebase/cgi/um?M=%2Ft20%2Fe260&O= inebase&N=&L=. [Last accessed: 1 July 2005]
-
Instituto Nacional de Estadistica de España (Nacional Institute of Statistics of Spain). Cifras de Población. Available at: http://www.ine.es/inebase/cgi/um?M=%2Ft20%2Fe260&O= inebase&N=&L=. [Last accessed: 1 July 2005]
-
-
-
-
26
-
-
27444443876
-
Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
-
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52
-
(2005)
Circulation
, vol.112
, pp. 2735-2752
-
-
Grundy, S.M.1
Cleeman, J.I.2
Daniels, S.R.3
-
27
-
-
22044449731
-
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects
-
Milionis HJ, Rizos E, Goudevenos J, et al. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005;36:1372-6
-
(2005)
Stroke
, vol.36
, pp. 1372-1376
-
-
Milionis, H.J.1
Rizos, E.2
Goudevenos, J.3
-
28
-
-
0030974651
-
Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study
-
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;17:1114-20
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 1114-1120
-
-
Jeppesen, J.1
Hein, H.O.2
Suadicani, P.3
Gyntelberg, F.4
-
29
-
-
0037480160
-
High-density vs. low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age
-
Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, et al. High-density vs. low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003;163:1549-54
-
(2003)
Arch Intern Med
, vol.163
, pp. 1549-1554
-
-
Weverling-Rijnsburger, A.W.1
Jonkers, I.J.2
van Exel, E.3
-
30
-
-
2542497645
-
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
-
Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Curr Med Res Opin 2004;20:627-37
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 627-637
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Papageorgiou, A.A.3
-
31
-
-
0032920672
-
Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events
-
Pfeffer MA, Sacks FM, Moyé LA, et al. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol 1999;33:125-30
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 125-130
-
-
Pfeffer, M.A.1
Sacks, F.M.2
Moyé, L.A.3
-
32
-
-
34748887666
-
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
-
Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-10
-
(2007)
N Engl J Med
, vol.357
, pp. 1301-1310
-
-
Barter, P.1
Gotto, A.M.2
LaRosa, J.C.3
-
33
-
-
0032562257
-
Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study
-
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998;97:1029-36
-
(1998)
Circulation
, vol.97
, pp. 1029-1036
-
-
Jeppesen, J.1
Hein, H.O.2
Suadicani, P.3
Gyntelberg, F.4
-
34
-
-
33846637379
-
Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 western prospective studies
-
Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 western prospective studies. Circulation 2007;115:450-8
-
(2007)
Circulation
, vol.115
, pp. 450-458
-
-
Sarwar, N.1
Danesh, J.2
Eiriksdottir, G.3
-
35
-
-
36248963194
-
Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients
-
Athyros VG, Kakafika AI, Papageorgiou AA, et al. Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. Lipids 2007;42:999-1009
-
(2007)
Lipids
, vol.42
, pp. 999-1009
-
-
Athyros, V.G.1
Kakafika, A.I.2
Papageorgiou, A.A.3
-
36
-
-
25144450879
-
Clinical practice. Low HDL cholesterol levels
-
Ashen MD, Blumenthal RS. Clinical practice. Low HDL cholesterol levels. N Engl J Med 2005;353:1252-60
-
(2005)
N Engl J Med
, vol.353
, pp. 1252-1260
-
-
Ashen, M.D.1
Blumenthal, R.S.2
-
37
-
-
33646410075
-
The effects of statins on high-density lipoproteins
-
Schaefer EJ, Asztalos BF. The effects of statins on high-density lipoproteins. Curr Atheroscler Rep 2006;8:41-9
-
(2006)
Curr Atheroscler Rep
, vol.8
, pp. 41-49
-
-
Schaefer, E.J.1
Asztalos, B.F.2
-
38
-
-
2442520797
-
Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: Assessing all reasonable doses with innovative surface graph analysis
-
Insull W Jr, McGovern ME, Schrott H, et al. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis. Arch Intern Med 2004;164:1121-7
-
(2004)
Arch Intern Med
, vol.164
, pp. 1121-1127
-
-
Insull Jr, W.1
McGovern, M.E.2
Schrott, H.3
-
39
-
-
0035865542
-
Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
-
Wolfe ML, Vartanian SF, Ross JL, et al. Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia. Am J Cardiol 2001;87:476-9
-
(2001)
Am J Cardiol
, vol.87
, pp. 476-479
-
-
Wolfe, M.L.1
Vartanian, S.F.2
Ross, J.L.3
-
40
-
-
34547205154
-
Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients
-
Birjmohun RS, Kastelein JJ, Poldermans D, et al. Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients. Curr Med Res Opin 2007;23:1707-13
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 1707-1713
-
-
Birjmohun, R.S.1
Kastelein, J.J.2
Poldermans, D.3
-
41
-
-
10044281651
-
Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
-
Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-17
-
(2004)
Circulation
, vol.110
, pp. 3512-3517
-
-
Taylor, A.J.1
Sullenberger, L.E.2
Lee, H.J.3
-
42
-
-
30144445801
-
Prolonged-release nicotinic acid: A review of its use in the treatment of dyslipidaemia
-
McCormack PL, Keating GM. Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs 2005;65:2719-40
-
(2005)
Drugs
, vol.65
, pp. 2719-2740
-
-
McCormack, P.L.1
Keating, G.M.2
-
43
-
-
34249024864
-
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1
-
Lai E, De Lepeleire I, Crumley TM, et al. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther 2007;81:849-57
-
(2007)
Clin Pharmacol Ther
, vol.81
, pp. 849-857
-
-
Lai, E.1
De Lepeleire, I.2
Crumley, T.M.3
-
44
-
-
4344665253
-
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C
-
Chapman MJ, Assmann G, Fruchart JC, et al. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004;20:1253-68
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 1253-1268
-
-
Chapman, M.J.1
Assmann, G.2
Fruchart, J.C.3
-
45
-
-
41149123132
-
-
Treatment of HDL to reduce the incidence of vascular events HPS2-THRIVE. Clinicaltrials.gov, NCT00461630. Available at: http://www.clinicaltrials.gov/ct/ show/NCT00461630?order=1 [Last accessed: 24 September 2007]
-
Treatment of HDL to reduce the incidence of vascular events HPS2-THRIVE. Clinicaltrials.gov, NCT00461630. Available at: http://www.clinicaltrials.gov/ct/ show/NCT00461630?order=1 [Last accessed: 24 September 2007]
-
-
-
-
46
-
-
35848945939
-
Effects of statins on renal function
-
Agarwal R. Effects of statins on renal function. Mayo Clin Proc 2007;82:13
-
(2007)
Mayo Clin Proc
, vol.82
, pp. 13
-
-
Agarwal, R.1
|